Baguio, Chaniel B.
HRN: 27-98-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2025
OXACILLIN 500MG (VIAL)
10/25/2025
11/01/2025
IV
200mg
Q6h
IMPETIGO
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes